Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma

American Journal of Dermatopathology

Volumn 21, Issue 2, 1999, Pages 146-150

  Asch, Pierre Henri ^e   Basset, Paul ^a   Roos, Michel ^b   Grosshans, Edward ^e   Bellocq, Jean Pierre ^c   Cribier, Bernard ^d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Unité de Biostatistique Facuté de Médecine   (France)

^c Serv d'Anat Pathologique Gen   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e NONE

Author keywords

Immunohistochemistry; Keratoacanthoma; Metalloproteinase; Squamous cell carcinoma; Stromelysin 3

Indexed keywords

MATRIX METALLOPROTEINASE; STROMELYSIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0032907891     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199904000-00006     Document Type: Article

References (22)

1. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991;5:2145-54.
3. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
4. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 1993;9:541-73.
5. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
6. Manes S, Mira E, Del Mar Barbacid M, et al. Identification of insulin-growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 1997;272: 25706-12.
7. Rouyer N, Wolf C, Chenard MP, et al. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994;70: 176-82.
8. Wolf C, Rouyer N, Lutz Y, et al. Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993;90:1843-7.
9. Engel G, Heselmeyer K, Auer G, Bäckdahl M, Eriksson E, Linder S. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer 1994;58:1-7.
10. Chenard MP, O'Siorain L, Shering S, et al. High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 1996;69:448-51.
11. Muller D, Wolf C, Abecassis J, et al. Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993;53:165-69.
12. Wolf C, Chenard MP, Durand de Grossouvre P, Bellocq JP, Chambon P, Basset P. Breast cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 1992;99:870-2.
13. Undén AB, Sandstedt B, Bruce K, Hedblad MA. Ståhle-Bäckdahl M. Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma. J Invest Dermatol 1996;107: 147-53.
14. Ackerman AB, Mendonĉa ANN, Guo Y. Differential Diagnosis in Dermatopathology, vol 1. Philadelphia: Lea & Febiger, 1992.
15. Santavicca M, Noel A, Chenard MP, et al. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semiquantitative immunohistochemistry. Int J Cancer 1995;64:336-41.
16. Majmudar G, Nelson BR, Jensen TC, Voorhees JJ, Johnson TM. Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinog 1994;9:17-23.
17. Wagner SN, Ruhri C, Kunth K, et al. Expression of stromelysin-3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol 1992;1:200-5.
18. Noel AC, Lefebvre O, Maquoi E, et al. Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 1996;97:1924-30.
19. Masson R, Lefebvre O, Noel A, et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 1998;140:1535-13.
20. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993;15:332-42.
21. Ledo E. Wart, keratoacanthoma and squamous cell carcinoma: a spectrum of the same neoplastic process? Int J Dermatol 1992;31: 777-8.
22. Lefebvre O, Régnier C, Chenard MP, et al. Developmental expression of mouse stromelysin-3 mRNA. Development 1995;121:947-55.